Fischer Medical Ventures (FISCHER) — Announcement

📢 Key Event
Fischer Medical Ventures secured CDSCO import approval for Spincare, India's first portable electrospun wound care system.

🔮 What's Next
Commercial rollout across India and Southeast Asia; FDA approval pending for Spincare.

💡 Investor Takeaway
Shareholders gain access to a high-growth wound care market with exclusive distribution rights and regulatory milestones.

Fischer Medical Ventures announced CDSCO approval for Spincare, India's first portable electrospun wound care system, granting exclusive distribution rights across India and Southeast Asia. The Class C medical device addresses chronic wounds, burns, and surgical incisions, targeting a $380 million Indian wound care market projected to hit $1.8 billion by 2033. Management highlighted immediate commercial rollout plans and global regulatory progress, including pending FDA clearance, positioning the company at the forefront of high-growth medical device segments.

📄 View Original Announcement (PDF)

📊 Stock Analysis — FISCHER ✨ Ask AI About This

About Fischer Medical Ventures Limited (FISCHER)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹2,261.37 Cr P/E: 59.0

View full FISCHER stock details →

📡 Get AI alerts when FISCHER files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FISCHER — Free

💡 Ask AI about this filing

"When will Spincare be commercially available in Indian hospitals?" "What is the revenue contribution timeline from Southeast Asia distribution?" "How does CDSCO approval impact Fischer's valuation relative to peers?"

Ask AI Free →

📊 More FISCHER filings

See all FISCHER filings →

🔥 Also filed on 30 July 2026

PARADEEP Paradeep Phosphates Limited Financial Results SYRMA Syrma SGS Technology Limited Offer Document AJANTPHARM Ajanta Pharma Limited Corporate Action GATEWAY Gateway Distriparks Limited Corporate Action AYMSYNTEX AYM Syntex Limited Announcement GILLETTE Gillette India Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FISCHER files new disclosures

Track FISCHER filings, board meetings, and corporate actions. Free email alerts at 5 PM.